These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3516833)

  • 21. Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption.
    Ebert R; Unger H; Creutzfeldt W
    Diabetologia; 1983 Jun; 24(6):449-54. PubMed ID: 6350081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of porcine GIP on insulin secretion and glucose clearance in the pig.
    Wolffbrandt KH; Damm Jørgensen K; Moody AJ; Pedersen PC
    Horm Metab Res; 1986 Mar; 18(3):159-62. PubMed ID: 3516832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J; de Pierluissi R; de Martínez A
    Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of oral galactose on GIP and insulin secretion in man.
    Morgan LM; Wright JW; Marks V
    Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression of insulin release by anti-GIP serum after oral glucose in rats.
    Lauritsen B; Holst JJ; Moody AJ
    Scand J Gastroenterol; 1981 Apr; 16(3):417-20. PubMed ID: 16435485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
    Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
    Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
    Sarson DL; Wood SM; Kansal PC; Bloom SR
    Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretion and action in the hyperthyroid rat.
    Varnum B; Davidson MB; Venkatesan N
    Horm Metab Res; 1985 Aug; 17(8):383-6. PubMed ID: 2865201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motility.
    Sullivan SN; Lee MG; Bloom SR; Lamki L; Dupré J
    Diabetes; 1986 Mar; 35(3):324-8. PubMed ID: 3512343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional enteroinsular axis in full-term newborn infants.
    King KC; Oliven A; Kalhan SC
    Pediatr Res; 1989 May; 25(5):490-5. PubMed ID: 2497435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
    Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
    Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.
    Meier JJ; Gallwitz B; Kask B; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetes; 2004 Dec; 53 Suppl 3():S220-4. PubMed ID: 15561915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
    Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.